ProQR Therapeutics NV (NASDAQ:PRQR)
| 1.83 Delayed Data As of 3:59pm ET |  -0.06 / -3.17%Today’s Change | 0.68 Today|||52-Week Range 3.85 | -50.54% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 103.1M | 62.4M | 57.8M | 120.7M | |
| Short Term Investment Cash | -19.8M | -39.5M | -12.5M | 67.8M | ||
| Cash & Short Term Investments | 103.1M | 62.4M | 57.8M | 120.7M | ||
| Receivables | Receivables | 1.6M | 1.7M | 563.2K | 2.4M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 1.5M | 1.3M | 2.4M | 737.3K | |
| Current Assets | 106.2M | 65.4M | 60.7M | 123.9M | ||
| Total Assets | Property, Plant and Equipment - Gross | 3.0M | 5.4M | 6.2M | 6.3M | |
| Depreciation | -622.4K | -1.7M | -3.2M | -4.1M | ||
| Intangible Assets | 153.2K | 94.9K | 46.8K | 0.00 | ||
| Other Assets | 153.2K | 94.9K | 46.8K | 0.00 | ||
| Total Assets | 108.7M | 69.1M | 63.8M | 126.0M | ||
| Liabilities | Accounts Payable | 961.4K | 346.0K | 655.6K | 154.3K | |
| Short Term Debt | 16.3K | 0.00 | 2.4M | 0.00 | ||
| Accrued Expenses | 4.6M | 0.00 | 5.6M | 8.5M | ||
| Other Current Liabilities | 5.0M | 6.7M | 7.2M | 9.2M | ||
| Other Liabilities | 6.0M | 7.1M | 10.2M | 9.3M | ||
| Total Liabilities | Long Term Debt | 5.2M | 4.8M | 6.3M | 8.0M | |
| Other Liabilities | 0.00 | 1.2M | 0.00 | 2.7M | ||
| Total Liabilities | 11.2M | 13.1M | 16.5M | 20.1M | ||
| Equity | Minority Interest | 0.00 | 0.00 | -42.9K | -226.5K | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 97.5M | 56.0M | 47.3M | 106.2M | ||
| Total Shareholder Equity | 97.5M | 56.0M | 47.3M | 106.2M | ||
| Share Information | Common Shares Outstanding | 23.3M | 23.3M | 31.9M | 43.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
